Rothblatt Martine A sold 200 shares of UNITED THERAPEUTICS Corp at $594.60 for −$119k on Nov 16, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chairperson & CEO
Chairperson & CEO
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$118,920.80Shares × reported price
Shares traded
200Common Stock
Price per share
$594.60Reported price. Read footnotes for ranges.
% of reported position traded
0.06%This security and ownership context
Holdings after
324,563Indirect · by Trust
Trade date
Nov 16, 2026Sell
Filed
Nov 17, 2026, 4:48 PM ET1-day reporting delay
Accession
0001106578-26-000190Code S · Transaction 403862
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 324,763 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 16, 2026Sell110$580.25−$63,827.82Trade 403849
Nov 16, 2026Sell170$581.25−$98,812.69Trade 403850
Nov 16, 2026Sell280$582.18−$163,010.37Trade 403851
Nov 16, 2026Sell240$583.61−$140,066.02Trade 403852
Nov 16, 2026Sell640$584.54−$374,103.94Trade 403853
Nov 16, 2026Sell1,382$585.83−$809,620.65Trade 403854
Nov 16, 2026Sell2,108$586.72−$1,236,796.06Trade 403855
Nov 16, 2026Sell1,090$587.61−$640,491.96Trade 403856
Nov 16, 2026Sell835$588.59−$491,474.99Trade 403857
Nov 16, 2026Sell575$590.25−$339,391.39Trade 403858
Nov 16, 2026Sell996$591.26−$588,891.47Trade 403859
Nov 16, 2026Sell514$592.05−$304,312.16Trade 403860
Nov 16, 2026Sell240$593.16−$142,357.87Trade 403861
Nov 16, 2026Sell120$595.19−$71,422.80Trade 403863
Nov 16, 2026Option exercise9,500$117.76$1,118,720Trade 403848
Nov 16, 2026Option exercise9,500$0.00$0Trade 403864
17 transaction rows in this filing. Joint filers share the same rows.

UTHR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
UTHR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −8.7%1w ago −0.3%1d ago +1.2%
Returns since7d30d90d180d1y

Footnotes in full

F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026. F10: This transaction was executed in multiple trades at prices ranging from $587.24 to $587.985. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F11: This transaction was executed in multiple trades at prices ranging from $588.24 to $589.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F12: This transaction was executed in multiple trades at prices ranging from $589.63 to $590.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F13: This transaction was executed in multiple trades at prices ranging from $590.63 to $591.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F14: This transaction was executed in multiple trades at prices ranging from $591.63 to $592.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F15: This transaction was executed in multiple trades at prices ranging from $592.99 to $593.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F16: This transaction was executed in multiple trades at prices ranging from $594.08 to $595.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F17: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. F18: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries. F19: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. F2: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. F20: These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023. F21: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries. F3: This transaction was executed in multiple trades at prices ranging from $579.65 to $580.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4: This transaction was executed in multiple trades at prices ranging from $580.72 to $581.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5: This transaction was executed in multiple trades at prices ranging from $581.74 to $582.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F6: This transaction was executed in multiple trades at prices ranging from $583.02 to $583.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F7: This transaction was executed in multiple trades at prices ranging from $584.08 to $584.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F8: This transaction was executed in multiple trades at prices ranging from $585.22 to $586.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F9: This transaction was executed in multiple trades at prices ranging from $586.22 to $587.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.